Since its founding in 1998, CONGEN Biotechnologie GmbH has been an innovative Berlin biotechnology company in the field of molecular DNA and RNA analysis. Our core competency is the development and application of real-time PCR methods for food- and wateranalyses, clinical and Point-of-care diagnostics and companion diagnostics. Each detection method is developed by us in house and validated in respect of the requirements of standards, customers and/or the market. Our products are marketed worldwide by us and our distribution partner R-Biopharm under the brand names SureFood®, SureFast®, RIDA® GENE and RIDA® PRECISION.
As a competence laboratory, we offer our customers a number of accredited analysis procedures in our service laboratory and our approved S2 laboratory.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Robert-Rössle-Straße, Haus 55,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- congen.de
- Keywords
- in-vitro Diagnostik.
- HQ
- Berlin, Berlin
Congen Biotechnologie Gmbh Questions
Congen Biotechnologie Gmbh's website is congen.de
Congen Biotechnologie Gmbh's LinkedIn profile is https://de.linkedin.com/company/congen
Congen Biotechnologie Gmbh has
15 employees.
View email and phone details for 15
employees at Congen Biotechnologie Gmbh.
Congen Biotechnologie Gmbh's industry is
Biotechnology Research
Congen Biotechnologie Gmbh's top competitors are
Aokin Ag,
Biotest Ag,
Bundesinstitut Für Risikobewertung,
Omeicos Therapeutics Gmbh,
Quartett Biotechnologie Gmbh,
Hypharm,
Proteros Biostructures Gmbh,
Hypharm Gmbh,
Microcoat Biotechnologie Gmbh,
Ahn Biotechnologie Gmbh.
Congen Biotechnologie Gmbh's categories are Biotechnology Research
Congen Biotechnologie Gmbh's founding year is 1998
